Evaluate ABEO stock safety — financial health, volatility, institutional backing, and risk factors.

What are the risks of investing in ABEO? | Glauxie AI

Q: What are the risks of investing in ABEO?

Abeona Therapeutics Inc. (ABEO) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Vishwas Seshadri. Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous,... Employees: 226.

Q: How much debt does ABEO have?

Review ABEO total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Q: Is ABEO a good long-term investment?

Evaluate ABEO as a long-term investment using fundamental scores, growth metrics, and risk assessment.

What are the risks of investing in ABEO?

🦉

Abeona Therapeutics Inc. (ABEO)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOVishwas Seshadri

Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis...

Key Executives

Name	Title
Alison Hardgrove	Chief People Officer
Brendan O'Malley	Chief Legal Officer
Brian Kevany	Chief Technical & Scientific Officer
Carl Denny	Senior Vice President of Regulatory Affairs
Gianine Esposito	Senior VP & Chief People Officer
Gregory Gin	Vice President of Investor Relations & Corporation Communications

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

ABEO Profile Financials

Is ABEO stock safe? How much debt does ABEO have? Is ABEO a good long-term investment?